Rare diseases
Investigational molecules
Locations
VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk
CzechiaNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
CzechiaLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
CzechiaPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
CzechiaStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
CzechiaObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
CzechiaRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
CzechiaIfinatamab deruxtecan in Patients With Advanced Esophageal Squamous Cell Carcinoma
CzechiaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
CzechiaA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
CzechiaComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
CzechiaPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
